Literature DB >> 23465649

Extreme face-to-face positioning for cataract surgery with patient seated upright in motorized wheelchair.

Mykolas Pajaujis1, Anas Injarie, Tom Eke.   

Abstract

We present a case of extreme positioning for cataract surgery. The 68-year-old man was unable to lie flat and found it difficult to transfer from his motorized wheelchair. He had poor mobility due to a stroke, slept upright because of orthopnea, and his neck extension was poor. After the options and risks were discussed, surgery was performed under topical intracameral anesthesia using face-to-face positioning with the patient seated upright in his wheelchair. The operating microscope was rotated toward the horizontal, and the surgeon stood at the patient's side with the patient's face almost upright. The right-handed surgeon used a temporal corneal incision (0 degree) in the left eye and an inferior incision (270 degrees) in the right eye. Surgery and recovery were uneventful. Given a preexisting epiretinal membrane in the left eye, the patient was very happy with the uncorrected distance visual acuity outcome of 6/9 in the right eye and 6/18 in the left eye.
Copyright © 2013 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23465649     DOI: 10.1016/j.jcrs.2013.01.029

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  2 in total

1.  Facilitating Role of the 3D Viewing System in Tilted Microscope Positions for Cataract Surgery in Patients Unable to Lie Flat.

Authors:  Otman Sandali; Rachid Tahiri Joutei Hassani; Ashraf Armia Balamoun; Mohamed El Sanharawi; Vincent Borderie
Journal:  J Clin Med       Date:  2022-03-28       Impact factor: 4.241

2.  PHACOSIT: A sitting phacoemulsification technique for patients unable to lie down flat during cataract surgery.

Authors:  Jebinth Brayan; Prithvi Chandrakanth; Siddharth Narendran; Kalpana Narendran; Venkatapathy Narendran
Journal:  Indian J Ophthalmol       Date:  2022-04       Impact factor: 2.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.